Comments on drugs difficult to compound and the quality of chemicals to be used in compounding.
These comments are minor modifications to the material submitted by the author to the docket for the FDA Pharmacy Compounding Committee that met on October 15 and 16, 1998.
Perrin
J H
JH
University of Florida, USA.
D000280:Administration, Inhalation; D003692:Delayed-Action Preparations / Q000737:chemistry; D004339:Drug Compounding / Q000379:methods*; D017408:Guidelines as Topic; D007263:Infusions, Parenteral
D003692:Delayed-Action Preparations